Benitec Biopharma

BNTCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$468.250 M

$13.63 +3.81%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$37.9M

Loss-making

Shares outstanding

34,354,334

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#211Aquestive TherapeuticsAQST$494.3M
#212Ovid TherapeuticsOVID$490.9M
#213Benitec BiopharmaBNTC$468.2M
#214Q32 BioQTTB$464.4M
#215Prothena Corp PublicPRTA$458.6M

Where these numbers come from

Share counts and financials for Benitec Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.